BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28863969)

  • 1. Soluble Interleukin-7 receptor levels and risk of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Kielsen K; Shamim Z; Thiant S; Faucher S; Decker W; Christensen IJ; Ryder LP; Yakoub-Agha I; Müller K
    Clin Immunol; 2018 Feb; 187():26-32. PubMed ID: 28863969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor Genotype in the Interleukin-7 Receptor α-Chain Predicts Risk of Graft-versus-Host Disease and Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation.
    Kielsen K; Enevold C; Heilmann C; Sengeløv H; Pedersen AE; Ryder LP; Müller K
    Front Immunol; 2018; 9():109. PubMed ID: 29456530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced plasma levels of soluble interleukin-7 receptor during graft-versus-host disease (GVHD) in children and adults.
    Poiret T; Rane L; Remberger M; Omazic B; Gustafsson-Jernberg A; Vudattu NK; Ahmed R; Ernberg I; Winiarski J; Magalhaes I; Ringden O; Maeurer M
    BMC Immunol; 2014 Jun; 15():25. PubMed ID: 24946690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble interleukin-27 receptor alpha is a valuable prognostic biomarker for acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Liu S; Han J; Gong H; Li Y; Bao X; Qi J; Liu H; Chen J; Wu X; Xu Y; Ma S; Wu D
    Sci Rep; 2018 Jul; 8(1):10328. PubMed ID: 29985424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T cell reconstitution in allogeneic haematopoietic stem cell transplantation: prognostic significance of plasma interleukin-7.
    Kielsen K; Jordan KK; Uhlving HH; Pontoppidan PL; Shamim Z; Ifversen M; Heilmann C; Nielsen CH; Sengeløv H; Ryder LP; Müller KG
    Scand J Immunol; 2015 Jan; 81(1):72-80. PubMed ID: 25263171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and biochemical characterization of human plasma soluble IL-7R: lower concentrations in HIV-1-infected patients.
    Rose T; Lambotte O; Pallier C; Delfraissy JF; Colle JH
    J Immunol; 2009 Jun; 182(12):7389-97. PubMed ID: 19494261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: Impact of interleukin-7.
    Kielsen K; Ryder LP; Lennox-Hvenekilde D; Gad M; Nielsen CH; Heilmann C; Ifversen M; Pedersen AE; Müller K
    Immunobiology; 2018 Feb; 223(2):220-226. PubMed ID: 29033080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of inflammatory cytokine gene polymorphisms on developing acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell transplantation.
    Masetti R; Zama D; Urbini M; Astolfi A; Libri V; Vendemini F; Morello W; Rondelli R; Prete A; Pession A
    J Immunol Res; 2015; 2015():248264. PubMed ID: 25973432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
    Kreft KL; Verbraak E; Wierenga-Wolf AF; van Meurs M; Oostra BA; Laman JD; Hintzen RQ
    Genes Immun; 2012 Oct; 13(7):587-92. PubMed ID: 22914435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble interleukin-6 receptors in hematology patients undergoing bone marrow transplantation.
    Toren A; Novick D; Or R; Ackerstein A; Slavin S; Nagler A
    Transplantation; 1996 Jul; 62(1):138-42. PubMed ID: 8693533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of IL-1β -511 polymorphism with severe veno-occlusive disease in pediatric-matched allogeneic hematopoietic stem cell transplantation.
    Elbahlawan L; McArthur J; Quasney MW; Pei D; Srivastava K; Dahmer MK; Barfield R
    J Pediatr Hematol Oncol; 2012 Apr; 34(3):175-9. PubMed ID: 22395218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A study on the relations of soluble interleukin-2 receptor and CD+25 cell with acute graft-versus-host disease].
    Ju X; Wang J; Zhang W; Song X; Zhou K; Gong S
    Zhonghua Nei Ke Za Zhi; 2001 Apr; 40(4):222-5. PubMed ID: 11798579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pilot study of single nucleotide polymorphisms in the interleukin-6 receptor and their effects on pre- and post-transplant serum mediator level and outcome after allogeneic stem cell transplantation.
    Tvedt THA; Hovland R; Tsykunova G; Ahmed AB; Gedde-Dahl T; Bruserud Ø
    Clin Exp Immunol; 2018 Jul; 193(1):130-141. PubMed ID: 29513361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the interleukin-7 receptor-alpha and outcome after allogeneic hematopoietic cell transplantation with matched unrelated donor.
    Shamim Z; Spellman S; Haagenson M; Wang T; Lee SJ; Ryder LP; Müller K
    Scand J Immunol; 2013 Aug; 78(2):214-20. PubMed ID: 23692589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
    Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
    Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating IL-17 levels during the peri-transplant period as a predictor for early leukemia relapse after myeloablative allogeneic stem cell transplantation.
    Cho BS; Lim JY; Yahng SA; Lee SE; Eom KS; Kim YJ; Chung NG; Jeong DC; Lee S; Kim HJ; Cho SG; Kim DW; Lee JW; Min WS; Park CW; Min CK
    Ann Hematol; 2012 Mar; 91(3):439-48. PubMed ID: 21894475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between IL1B (+3954) polymorphisms and IL-1β levels in blood and saliva, together with acute graft-versus-host disease.
    Resende RG; Abreu MH; de Souza LN; Silva ME; Gomez RS; Correia-Silva Jde F
    J Interferon Cytokine Res; 2013 Jul; 33(7):392-7. PubMed ID: 23659674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine levels and acute graft-versus-host disease after HLA-identical hematopoietic stem cell transplantation.
    Visentainer JE; Lieber SR; Persoli LB; Vigorito AC; Aranha FJ; de Brito Eid KA; Oliveira GB; Miranda EC; de Souza CA
    Exp Hematol; 2003 Nov; 31(11):1044-50. PubMed ID: 14585368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of plasma cytokines after hematopoietic stem cell transplantation from unrelated donors: the ratio of plasma IL-10/sTNFR level as a potential prognostic marker in severe acute graft-versus-host disease.
    Sakata N; Yasui M; Okamura T; Inoue M; Yumura-Yagi K; Kawa K
    Bone Marrow Transplant; 2001 Jun; 27(11):1153-61. PubMed ID: 11551026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.